Sidrah Shah
Overview
Explore the profile of Sidrah Shah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah S, Shaing C, Khatib J, Lodrigues W, Dreadin-Pulliam J, Anderson B, et al.
Clin Breast Cancer
. 2022 Sep;
22(8):823-827.
PMID: 36089460
Introduction: Extended endocrine therapy (EET) benefits select patients with early-stage hormone-receptor positive (HR+) breast cancer (BC) but also incurs side effects and cost. The Clinical Treatment Score at Five Years...
2.
Shah S, Cheung A, Kutka M, Sheriff M, Boussios S
Int J Environ Res Public Health
. 2022 Jul;
19(13).
PMID: 35805770
Epithelial ovarian cancer (EOC) is one of the cancers most influenced by hereditary factors. A fourth to a fifth of unselected EOC patients carry pathogenic variants (PVs) in a number...
3.
Papadopoulou S, Pavlidou E, Argyris G, Flouda T, Koukoutsidi P, Krikonis K, et al.
J Pers Med
. 2022 Apr;
12(4).
PMID: 35455763
Although the impact of epilepsy on expressive language is heavily discussed, researched, and scientifically grounded, a limited volume of research points in the opposite direction. What about the causal relationship...
4.
Cheung A, Shah S, Parker J, Soor P, Limbu A, Sheriff M, et al.
Int J Environ Res Public Health
. 2022 Feb;
19(3).
PMID: 35162125
Non-epithelial ovarian cancers (NEOC) are a group of uncommon malignancies that mainly includes germ cell tumours (GCT), sex cord-stromal tumours (SCST), and some extremely rare tumours, such as small cell...
5.
Shah S, Rachmat R, Enyioma S, Ghose A, Revythis A, Boussios S
Int J Mol Sci
. 2021 Dec;
22(23).
PMID: 34884434
Prostate cancer ranks fifth in cancer-related mortality in men worldwide. DNA damage is implicated in cancer and DNA damage response (DDR) pathways are in place against this to maintain genomic...
6.
Revythis A, Shah S, Enyioma S, Ghose A, Patel M, Karathanasi A, et al.
Int J Environ Res Public Health
. 2021 Oct;
18(19).
PMID: 34639712
The COVID-19 pandemic has undoubtedly affected all national healthcare systems at different levels. In countries heavily hit by the pandemic, it was reported that healthcare workers were asked to work...
7.
Ioannidou E, Moschetta M, Shah S, Parker J, Ozturk M, Pappas-Gogos G, et al.
Int J Mol Sci
. 2021 Sep;
22(18).
PMID: 34576107
Prostate cancer (PC) is the most common cancer in men and the second leading cause of cancer-related death worldwide. Many therapeutic advances over the last two decades have led to...
8.
Revythis A, Shah S, Kutka M, Moschetta M, Ozturk M, Pappas-Gogos G, et al.
Diagnostics (Basel)
. 2021 Aug;
11(8).
PMID: 34441278
The use of biomarkers in medicine has become essential in clinical practice in order to help with diagnosis, prognostication and prediction of treatment response. Since Alexander Breslow's original report on...
9.
Grover S, Ning M, Bale M, Lichter K, Shah S, Bvochora-Nsingo M, et al.
Int J Gynecol Cancer
. 2021 Jul;
31(9):1220-1227.
PMID: 34312220
Objective: Cervical cancer remains the most common cancer among women in sub-Saharan Africa and is also a leading cause of cancer related deaths among these women. The benefit of chemoradiation...
10.
Boussios S, Rassy E, Shah S, Ioannidou E, Sheriff M, Pavlidis N
Expert Opin Ther Targets
. 2021 Jul;
25(5):329-333.
PMID: 34225539
No abstract available.